Kyverna Therapeutics Cash Flow Statement 2022-2024 | KYTX

Fifteen years of historical annual cash flow statements for Kyverna Therapeutics (KYTX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022
$-60.37$-28.89
$1.71$1.05
$2.83$2.06
$4.53$3.11
$0$0
$0$0
$4.08$0.68
$-2.06$-9.65
$3.42$-10.33
$-52.41$-36.11
$-0.62$-0.77
$0$0
$0$0
$-8.16$-13.33
$0$0
$-8.16$-13.33
$0$0
$-8.79$-14.10
$59.12$11.71
$0$0
$59.12$11.71
$0.65$0.18
$0.65$0.18
$0$0
$-1.65$0
$58.12$11.88
$-3.08$-38.33
$2.22$0.93
$0$0